Literature DB >> 10492142

Use of FDP and F1P aldolase to detect tumorous and nontumorous tissue damage by ethanol injection of hepatocellular carcinoma.

K N Khan1, K Nakata, K Nakao, Y Kato, K Eguchi.   

Abstract

Changes in serum levels of tumor-specific fructose 1,6-diphosphate (FDP) aldolase and nontumor-specific fructose 1-phosphate (F1P) aldolase activities were analyzed in patients with hepatocellular carcinoma (HCC) to detect the damage of tumorous and nontumorous hepatic cells after percutaneous ethanol injection (PEI). Initial PEI was performed in 20 patients containing 22 HCC nodules with a diameter of < or = 4 cm. Changes in serum hepatic enzyme activities were measured before and after repeated PEI. FDP and F1P aldolase levels were measured by substrate-specific enzymatic methods. Pre- and posttreatment alpha-fetoprotein (AFP) levels were determined by radioimmunoassay. The consequent changes in the total nontumorous liver volumes after PEI were also analyzed by follow-up CT scans. Serum levels of FDP aldolase released by ethanol injection were progressively increased (P < 0.0001) until the third PEI and thereafter decreased. In contrast, serum levels of F1P aldolase were continuously elevated even after the third PEI (P < 0.0001). Serum levels of transaminases were also elevated after repeated PEI (P < 0.0001). The FDP/FIP aldolase ratio decreased significantly with increased volume (>20 ml) of injected ethanol (P = 0.01) caused by nontumorous liver damage. The elevation of FDP aldolase was markedly associated with a decrease in serum levels of AFP (P < 0.001), indicating adequate tumor necrosis. The progression of the total nontumor liver atrophy depended on the volume of injected ethanol and correlated significantly with F1P aldolase levels after PEI (P < 0.01) but not with FDP aldolase. These results demonstrated that caution is needed to avoid nontumorous liver damage caused by the large volume of ethanol injection in treating HCC. Measurement of FDP and F1P aldolase activities in serum after PEI is clinically useful to detect the degree of tumorous and nontumorous tissue damage by ethanol.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492142     DOI: 10.1023/a:1026623312806

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

Review 1.  Transcatheter arterial embolization of hepatic neoplasms.

Authors:  K Nakata; K N Khan; S Nagataki
Journal:  Crit Rev Oncol Hematol       Date:  1992-09       Impact factor: 6.312

2.  Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma.

Authors:  S Shiina; K Tagawa; T Unuma; A Terano
Journal:  AJR Am J Roentgenol       Date:  1990-05       Impact factor: 3.959

3.  Absolute ethanol in thrombotherapy of bleeding esophageal varices.

Authors:  H Y Yune; E C Klatte; B D Richmond; F E Rabe
Journal:  AJR Am J Roentgenol       Date:  1982-06       Impact factor: 3.959

4.  Ablation of renal tumors with absolute ethanol: a new technique.

Authors:  B A Ellman; B J Parkhill; T S Curry; P B Marcus; P C Peters
Journal:  Radiology       Date:  1981-12       Impact factor: 11.105

5.  Subunit-specific radioimmunoassay for aldolase A, B, and C subunits: clinical significance.

Authors:  M Asaka; E Alpert
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

Review 6.  Treatment of small hepatocellular carcinomas.

Authors:  G M Dusheiko; K E Hobbs; R Dick; A K Burroughs
Journal:  Lancet       Date:  1992-08-01       Impact factor: 79.321

7.  Human aldolase B serum levels: a marker of liver injury.

Authors:  M Asaka; T Miyazaki; F B Hollinger; E Alpert
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

8.  Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress.

Authors:  F B Joseph; D A Baumgarten; M E Bernardino
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

9.  Small hepatocellular carcinoma: percutaneous alcohol injection--results in 23 patients.

Authors:  T Livraghi; A Salmi; L Bolondi; G Marin; V Arienti; F Monti; C Vettori
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

10.  Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients.

Authors:  M Ebara; M Ohto; N Sugiura; K Kita; M Yoshikawa; K Okuda; F Kondo; Y Kondo
Journal:  J Gastroenterol Hepatol       Date:  1990 Nov-Dec       Impact factor: 4.029

View more
  1 in total

Review 1.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.